Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postexposure prophylaxis

L I Lutwick1

  • 1Division of Infectious Diseases, Maimonides Medical Center, Brooklyn, NY 11219, USA.

Infectious Disease Clinics of North America
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Postexposure prophylaxis, including immunoglobulins or vaccines, is crucial for preventing infections like hepatitis A/B, measles, and rabies after exposure. Further research is needed for rubella, mumps, hepatitis C, HIV, and Lyme disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pneumocystis carinii pneumonia in pregnancy.

Chest·2001
Same author

Current and future treatment of Lyme disease.

Expert opinion on pharmacotherapy·2001
Same author

Brill-Zinsser disease.

Lancet (London, England)·2001
Same author

Childhood immunizations 2000. Introduction.

Pediatric clinics of North America·2000
Same author

Current update of pediatric hepatitis vaccine use.

Pediatric clinics of North America·2000
Same author

Pediatric immunization for the future. Lyme disease vaccine and beyond.

Pediatric clinics of North America·2000
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Postexposure prophylaxis (PEP) involves administering immunologic (vaccine, immunoglobulin) or antimicrobial agents after potential exposure to infectious agents.
  • PEP is established for preventing diseases such as viral hepatitis A and B, measles, varicella, rabies, and tuberculosis.
  • Evidence for PEP efficacy in rubella and mumps is less robust, and data are lacking for hepatitis C, human immunodeficiency virus (HIV), and Lyme borreliosis.

Purpose of the Study:

  • To review the current evidence and guidelines for postexposure prophylaxis in various infectious disease scenarios.
  • To identify areas where further research is needed to support or establish PEP protocols.

Main Methods:

  • Literature review of studies and guidelines on postexposure prophylaxis for infectious diseases.

Related Experiment Videos

  • Analysis of the strength of evidence supporting PEP for different pathogens.

    • Main Results:

    • Established PEP protocols exist for hepatitis A, hepatitis B, measles, varicella, rabies, and tuberculosis.
    • Limited data support PEP for rubella and mumps.
    • Significant gaps in knowledge and data exist for postexposure prophylaxis in hepatitis C, HIV, and Lyme borreliosis.

    Conclusions:

    • Timely postexposure prophylaxis is a critical intervention for preventing numerous infectious diseases.
    • Further research is essential to develop and validate PEP strategies for hepatitis C, HIV, and Lyme borreliosis.
    • This review highlights the importance of evidence-based prophylaxis and identifies key areas for future investigation.